For the quarter ending 2026-03-31, YCBD made $5,640,059 in revenue. -$876,783 in net income. Net profit margin of -15.55%.
| Income Statement | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
| Total net sales | 5,640,059 | 5,016,904 | 4,720,770 | 4,606,796 |
| Cost of sales | 2,383,137 | 2,015,610 | 1,943,575 | 1,775,709 |
| Gross profit | 3,256,922 | 3,001,294 | 2,777,195 | 2,831,087 |
| Operating expenses | 4,057,706 | 3,287,582 | 3,463,011 | 3,735,773 |
| Loss from operations | -800,784 | -286,288 | -685,816 | -904,686 |
| Decrease of contingent liability | - | - | 0 | 0 |
| Decrease (increase) in fair value of convertible debt | 0 | 0 | 0 | 0 |
| Interest income | 2,806 | 3,157 | 5,848 | 9,414 |
| Loss before provision for income taxes | -797,978 | -283,131 | -679,968 | -895,272 |
| Benefit (expense) for income taxes | - | - | 0 | - |
| Net loss | -797,978 | -283,131 | -679,968 | -895,272 |
| Preferred dividends | 78,805 | 41,471 | 0 | 333,500 |
| Net loss attributable to cbdmd, inc. common shareholders | -876,783 | -324,602 | -679,968 | -1,228,772 |
| Basic EPS | -0.08 | -0.04 | -0.169 | -0.21 |
| Diluted EPS | - | - | -0.169 | - |
| Basic Average Shares | 10,443,617 | 9,003,951 | 4,022,629* | 5,783,354 |
| Diluted Average Shares | - | - | 4,022,629 | - |
cbdMD, Inc. (YCBD)
cbdMD, Inc. (YCBD)